Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Menopause Knowledge Level and Myth Beliefs (Menopause)

28 maggio 2026 aggiornato da: Abdurrahim UYANIK, Tokat Gaziosmanpasa University

The Effect of Pecha Kucha and Traditional Education on Menopause Knowledge Level and Myth Beliefs: Randomized Controlled Trial

This study aims to compare the effects of the Pecha Kucha and PowerPoint presentation methods on menopause knowledge and beliefs in menopause-related myths. By introducing an innovative, concise, focused, and visually based approach to menopause education, this research is expected to strengthen health literacy, reduce myths, and contribute to the development of more positive attitudes toward menopause among women. Furthermore, by evaluating both menopause myths and different educational techniques together, this study is anticipated to be the first in the literature and to serve as a reference for future research.

Research questions:

  1. Does menopause-related knowledge increase among women who receive education using the Pecha Kucha technique and the PowerPoint method?
  2. Do beliefs in menopause-related myths decrease among women who receive education using the Pecha Kucha technique and the PowerPoint method?
  3. Is there a difference between the Pecha Kucha technique and the PowerPoint method in terms of women's menopause-related knowledge levels and their beliefs in menopause-related myths?

Panoramica dello studio

Descrizione dettagliata

Study Type

This study is designed as a randomized controlled trial.

Aim of the Study

This study aims to compare the effects of traditional PowerPoint and Pecha Kucha presentation methods on menopause knowledge and awareness of menopause myths among women in Türkiye.

Study Population and Sample

The study will be conducted online across Türkiye. Participants will be recruited via an Instagram announcement, and educational sessions will be delivered through Google Meet. Women who voluntarily apply through the online registration form and meet the eligibility criteria will be included.

Sample size was calculated using G*Power version 3.1.9.3. Since no similar study examining the effects of PowerPoint and Pecha Kucha presentation methods on menopause knowledge and awareness of menopause myths was identified in the literature, a large effect size was assumed (Cohen's d = 0.70) (Cohen, 1992). Based on a significance level of α = 0.05 and statistical power of 80% (1-β = 0.80), the minimum sample size was calculated as 72 participants, with 36 participants allocated to each group.

Randomization and Blinding

Eligible participants will be assigned independent identification codes by a researcher not involved in data analysis. Randomization will be performed using the "List Randomizer" tool on Random.org with a 1:1 allocation ratio. Participants will be randomly assigned to either the Pecha Kucha (P-K) group or the PowerPoint (PPT) group.

Participants will be informed that a menopause-related educational study is being conducted but will not be informed about the Pecha Kucha method before allocation. Outcome data will be analyzed by an independent statistician blinded to group assignments.

Intervention Pecha Kucha Group (P-K)

Participants in the P-K group will receive menopause education through the Pecha Kucha presentation format consisting of 20 slides displayed for 20 seconds each (total duration: 6 minutes and 40 seconds). The presentation will include highly visual materials with minimal text.

PowerPoint Group (PPT)

Participants in the PPT group will receive the same educational content using a traditional PowerPoint presentation format. The session will consist of approximately 30 slides and last 30-35 minutes.

Both groups will be trained by the same educator in separate online sessions. Educational content will include:

Definition and physiology of menopause Hormonal changes during menopause Vasomotor, urogenital, and psychosocial symptoms Common menopause myths and misconceptions Effects of myths on women's health and quality of life Evidence-based menopause information Healthy lifestyle behaviors during menopause Data Collection Procedure

Online questionnaires will be completed immediately before and after the educational intervention. Data collection will be conducted via Google Meet in a single-session format, and completion of the forms will require approximately 10-15 minutes.

Statistical Analysis

Data will be analyzed using IBM SPSS Statistics version 25.0. Descriptive statistics will be presented as frequencies, percentages, mean, and standard deviation. Normality will be assessed using the Kolmogorov-Smirnov test. Within-group pretest-posttest comparisons will be analyzed using paired samples t-tests, while between-group differences will be assessed using independent samples t-tests. Non-parametric equivalents (Wilcoxon signed-rank test and Mann-Whitney U test) will be used for non-normally distributed data. Statistical significance will be accepted at p < 0.05.

Ethical Considerations

Ethical approval will be obtained from the Tokat Gaziosmanpaşa University Human Research Ethics Committee. Written and verbal informed consent will be obtained from all participants prior to data collection. Participant confidentiality will be maintained, and personal data will be used solely for research purposes. Participants may withdraw from the study at any stage without penalty. The study will be conducted in accordance with the principles of the Declaration of Helsinki.

Tipo di studio

Interventistico

Iscrizione (Effettivo)

500

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Luoghi di studio

    • Tokat Province
      • Erbaa, Tokat Province, Turchia (Türkiye), 60500
        • Tokat Gaziosmanpasa University

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

  • Adulto
  • Adulto più anziano

Accetta volontari sani

Descrizione

Inclusion Criteria:

  • Being between 30 and 65 years of age (the lower age limit of 30 years was determined to establish a methodological threshold between young adulthood, in which menopause perception has not yet developed, and the menopausal transition period)
  • Being female
  • Volunteering to participate in the study
  • Not having previously received education about menopause
  • Being able to use technological devices
  • Being able to understand Turkish

Exclusion Criteria:

  • Being outside the 30-65 age range
  • Having a history of prior menopause-related education or formal training
  • Having cognitive, psychiatric, or medical conditions that could impair the ability to understand and complete the study procedures or questionnaires

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Ricerca sui servizi sanitari
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Separare

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Comparatore attivo: Pecha Kucha
A presentation consisting of 20 slides, supported by high-resolution visual materials and lasting 6 minutes and 40 seconds, was delivered. Each slide was displayed for 20 seconds as planned. The training included fundamental information about the menopausal period and addressed commonly encountered myths and misconceptions.
A presentation consisting of 20 slides, supported by high-resolution visual materials and lasting 6 minutes and 40 seconds, was delivered. Each slide was displayed for 20 seconds as planned. The training included fundamental information about the menopausal period and addressed commonly encountered myths and misconceptions
Comparatore attivo: PowerPoint group
Participants in this group received education on menopause and menopause-related myths using the PowerPoint presentation method. The same content was delivered by the same educator using the PowerPoint format. The presentation consisted of 30 slides and lasted approximately 35 minutes.
Participants in this group received education on menopause and menopause-related myths using the PowerPoint presentation method. The same content was delivered by the same educator using the PowerPoint format. The presentation consisted of 30 slides and lasted approximately 35 minutes.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Menopause Knowledge
Lasso di tempo: 1 hour
Menopause Knowledge Scale The scale developed by Mete et al. (2024) is a 5-point Likert-type scale. The items of the Menopause Knowledge Scale can be summed, and an increase in the score indicates increased knowledge of menopause. A minimum total score of 14 and a maximum total score of 70 can be obtained from the scale. Knowledge of Menopause Symptoms and Management (Factor 1) consists of questions 6, 7, 8, 9, 10, 11, 12, 13, and 14, with a minimum score of 9 and a maximum score of 45. General Menopause Knowledge (Factor 2) consists of questions 1, 2, 3, 4, and 5, with a minimum score of 5 and a maximum score of 25. The internal consistency Cronbach's alpha reliability coefficient of the scale is 0.917, 0.830 for Factor 1, and 0.908 for Factor 2.
1 hour

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Menopause Myths
Lasso di tempo: 1 hour
Menopause Myths Scale The Menopause Myths Scale (MMS), developed by Erol and Beydağ (2025), is a 5-point Likert-type scale designed to assess misconceptions about the menopausal process. The scale consists of 13 items and three sub-dimensions. The sub-dimensions are: "Myths regarding the impact on sexual life" (items 1-6), "Myths regarding the impact on family and social life" (items 7-10), and "Myths regarding the impact on mental health" (items 11-13). In the study where the scale was developed, the Cronbach's alpha coefficient was determined as 0.87; it was reported as 0.85 for the sub-dimensions "Myths regarding the impact on sexual life", and 0.79 for "Myths regarding the impact on family and social life" and "Myths regarding the impact on mental health". The maximum score that can be obtained from the scale is 65. The minimum score is 13. It is stated that as the score increases, the belief in myths also increases.
1 hour

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

15 febbraio 2026

Completamento primario (Effettivo)

16 febbraio 2026

Completamento dello studio (Effettivo)

20 febbraio 2026

Date di iscrizione allo studio

Primo inviato

22 maggio 2026

Primo inviato che soddisfa i criteri di controllo qualità

28 maggio 2026

Primo Inserito (Effettivo)

3 giugno 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

3 giugno 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

28 maggio 2026

Ultimo verificato

1 maggio 2026

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • Gaziosmanpasa- AUGE

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

NO

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Prove cliniche su Pecha Kucha group

Sottoscrivi